Correction to: Progressive multifocal leukoencephalopathy in rituximab-treated rheumatic diseases: a rare event

Joseph R Berger; Vineeta Malik; Stuart Lacey; Paul Brunetta; Patricia B Lehane

doi:10.1007/s13365-018-0637-1

Correction to: Progressive multifocal leukoencephalopathy in rituximab-treated rheumatic diseases: a rare event

J Neurovirol. 2018 Jun;24(3):332. doi: 10.1007/s13365-018-0637-1.

Authors

Joseph R Berger¹, Vineeta Malik², Stuart Lacey³, Paul Brunetta⁴, Patricia B Lehane³

Affiliations

¹ Department of Neurology, Perelman School of Medicine, University of Pennsylvania, 3400 Convention Avenue, Room 765, Philadelphia, PA, 19104, USA. joseph.berger@uphs.upenn.edu.
² F. Hoffmann-La Roche, Ltd., Basel, Switzerland.
³ Roche Products Ltd., Welwyn Garden City, UK.
⁴ Genentech, Inc, South San Francisco, USA.

Abstract

The article "Progressive multifocal leukoencephalopathy in rituximab-treated rheumatic diseases: a rare event," written by Joseph R. Berger, Vineeta Malik, Stuart Lacey, Paul Brunetta, and Patricia B. Lehane³, was originally published electronically on the publisher's internet portal (currently SpringerLink).

Publication types

Published Erratum